Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03386929
Title Survival Prolongation by Rationale Innovative Genomics (SPRING)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Worldwide Innovative Networking Association
Indications

lung non-small cell carcinoma

Therapies

Avelumab + Axitinib + Palbociclib

Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.